UBS AM’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-21,549
| Closed | -$241K | – | 2646 |
|
|
2017
Q3 | $241K | Buy |
21,549
+10,252
| +91% | +$115K | ﹤0.01% | 2167 |
|
|
2017
Q2 | $124K | Hold |
11,297
| – | – | ﹤0.01% | 2320 |
|
|
2017
Q1 | $111K | Hold |
11,297
| – | – | ﹤0.01% | 2290 |
|
|
2016
Q4 | $122K | Sell |
11,297
-22,800
| -67% | -$246K | ﹤0.01% | 2218 |
|
|
2016
Q3 | $349K | Hold |
34,097
| – | – | ﹤0.01% | 2183 |
|
|
2016
Q2 | $445K | Hold |
34,097
| – | – | ﹤0.01% | 2016 |
|
|
2016
Q1 | $375K | Sell |
34,097
-3,000
| -8% | -$33K | ﹤0.01% | 2092 |
|
|
2015
Q4 | $341K | Hold |
37,097
| – | – | ﹤0.01% | 2278 |
|
|
2015
Q3 | $257K | Hold |
37,097
| – | – | ﹤0.01% | 2376 |
|
|
2015
Q2 | $364K | Buy |
37,097
+6,800
| +22% | +$66.7K | ﹤0.01% | 2245 |
|
|
2015
Q1 | $268K | Buy |
30,297
+1,100
| +4% | +$9.73K | ﹤0.01% | 2330 |
|
|
2014
Q4 | $256K | Buy |
29,197
+3,000
| +11% | +$26.3K | ﹤0.01% | 2329 |
|
|
2014
Q3 | $180K | Hold |
26,197
| – | – | ﹤0.01% | 2412 |
|
|
2014
Q2 | $138K | Hold |
26,197
| – | – | ﹤0.01% | 2497 |
|
|
2014
Q1 | $119K | Hold |
26,197
| – | – | ﹤0.01% | 2531 |
|
|
2013
Q4 | $132K | Hold |
26,197
| – | – | ﹤0.01% | 2473 |
|
|
2013
Q3 | $133K | Hold |
26,197
| – | – | ﹤0.01% | 2421 |
|
|
2013
Q2 | $130K | Buy |
+26,197
| New | +$130K | ﹤0.01% | 2358 |
|